Trial intelligence / Profile preview

Glucosamine sulphate as adjunctive therapy for chronic periodontitis

NCT02214095Phase 1Terminated

Sponsor
Ain Shams University
Start
Jan 2012
Primary completion
Feb 2013
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of glucosamine sulphate in chronic periodontitis, sponsored by Ain Shams University. Primary endpoint: Interleukin-1 beta at 3 months. Started Jan 2012; status: terminated.

02

Drugs

glucosamine sulphate
03

Conditions

chronic periodontitis

Beyond the preview

Go deeper on NCT02214095.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02214095.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call